P Villain

1.2k citations
5 papers · 812 indexed · 1 hit paper · h-index 4
Topics
Antiplatelet Therapy and Cardiovascular Diseases (1 paper)Coronary Interventions and Diagnostics (1 paper)Cardiovascular Issues in Pregnancy (1 paper)
Partner nations
FranceUnited States

In The Last Decade

P Villain

5 papers receiving 765 citations

Hit Papers

Platelet Glycoprotein IIb/IIIa Inhibition with Coronary S...20012026200920172001250500750

Peers

P Villain
Comparison fields: 5 of 37
  • Cardiology and Cardiovascular Medicine 766
  • Surgery 544
  • Radiology, Nuclear Medicine and Imaging 256
  • Internal Medicine 123
  • Biomedical Engineering 47
Replace Albrecht Vogt with:
Albrecht Vogt Germany
Ullrich Schricke Germany
Nancy M. Wildermann United States
V. Gangadharan United States
Maurizio DʼUrbano Italy
K. L. Neuhaus Germany
Pascual Bordes Spain
Marlieke L.A. Haeck Netherlands
W. Jay Eldredge United States
H Oster Germany
P Villain relative to Albrecht Vogt Germany Albrecht Vogt's profile →
Citations per field
00.5×
Albrecht Vogt · 1×
Citations per year

Countries citing papers authored by P Villain

Since Specialization
Citations

This map shows the geographic impact of P Villain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Villain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Villain more than expected).

Fields of papers citing papers by P Villain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Villain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Villain. The network helps show where P Villain may publish in the future.

Co-authorship network of co-authors of P Villain

This figure shows the co-authorship network connecting the top 25 collaborators of P Villain. A scholar is included among the top collaborators of P Villain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Villain. P Villain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1
Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarctionbreakdown →
800
2
[Antiplatelet therapy during coronary endoprosthesis placement].
2
3
[Pilot study of the efficacy of ticlopidine in early patency of coronary endoprostheses].
4
4
[Diagnostic value of exercise tomoscintigraphy with thallium 201 in patients with complete left branch block].
3
5
[Has the prognosis of recent myocardial infarction changed?].
3

About P Villain

P Villain is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Infectious Diseases, having authored 5 papers that have together received 812 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (1 paper), Coronary Interventions and Diagnostics (1 paper) and Cardiovascular Issues in Pregnancy (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (766 citations), Internal Medicine (123 citations) and Surgery (544 citations). P Villain has collaborated with scholars based in France and United States. Frequent co-authors include Rémi Choussat, Marie‐Claude Morice, Olivier Wittenberg, Luc Maillard, Simon Elhadad, Gilles Montalescot, Philippe Pinton, Michel Pansiéri, Paul Barragan and A Serradimigni. Their work appears in journals such as New England Journal of Medicine and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026